Home / Market Reports / Medical Devices & Consumables / Global Benchtop NGS Sequencers Market Growth 2024-2030

Global Benchtop NGS Sequencers Market Growth 2024-2030

Global Benchtop NGS Sequencers Market Growth 2024-2030

Product Code:1243754

Published Date: Dec 07,2024

Pages: 130

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global Benchtop NGS Sequencers market size is predicted to grow from US$ 700 million in 2024 to US$ 1384 million in 2030; it is expected to grow at a CAGR of 12.0% from 2024 to 2030.

The desktop NGS sequencer is a compact, next-generation high-throughput sequencing device that is easy to use on the laboratory desktop. It provides fast and accurate gene sequence analysis capabilities. Its advantages are small size, easy installation and maintenance, while maintaining efficient data output and high-quality sequencing results. Features include a user-friendly operating interface, short sequencing time, low cost, and high sequencing throughput, making the desktop NGS sequencer an ideal gene analysis tool in scientific research and clinical laboratories, especially for small and medium-scale sequencing projects.

United States market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Benchtop NGS Sequencers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Benchtop NGS Sequencers players cover Illumina, ELEMENT BIOSCIENCES, CD Genomics, Singular Genomics Systems, Spectrum, etc. In terms of revenue, the global two largest companies occupied for a share nearly 
 % in 2023.

LP Information, Inc. (LPI) ' newest research report, the “Benchtop NGS Sequencers Industry Forecast” looks at past sales and reviews total world Benchtop NGS Sequencers sales in 2023, providing a comprehensive analysis by region and market sector of projected Benchtop NGS Sequencers sales for 2024 through 2030. With Benchtop NGS Sequencers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Benchtop NGS Sequencers industry.

This Insight Report provides a comprehensive analysis of the global Benchtop NGS Sequencers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Benchtop NGS Sequencers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Benchtop NGS Sequencers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Benchtop NGS Sequencers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Benchtop NGS Sequencers.

This report presents a comprehensive overview, market shares, and growth opportunities of Benchtop NGS Sequencers market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    DNA Library Preparation
    RNA Library Preparation
    ChIP Library Preparation

Segmentation by Application:
    Clinical Testing
    Scientific Research

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    Illumina
    ELEMENT BIOSCIENCES
    CD Genomics
    Singular Genomics Systems
    Spectrum
    Thermo Fisher
    QIAGEN
    Perkin Elmer
    Agilent Technologies
    Tecan
    Beckman Coulter
    INTEGRA Biosciences AG
    AUTOMATA
    Difei Medical Technology (Nanjing)
    Hangzhou Matridx Biotechnology
    Shanghai 3D Medicines
    MobiDrop (Zhejiang)
    GUANGDONG MGI TECH

Key Questions Addressed in this Report
What is the 10-year outlook for the global Benchtop NGS Sequencers market?
What factors are driving Benchtop NGS Sequencers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Benchtop NGS Sequencers market opportunities vary by end market size?
How does Benchtop NGS Sequencers break out by Type, by Application?